Radial Versus Femoral Approach for Percutaneous Coronary Intervention: MACE Outcomes at Long-Term Follow-up

J Invasive Cardiol. 2018 Jul;30(7):262-268.

Abstract

Objective: To compare the main outcomes of radial versus femoral access at long-term follow-up.

Background: Little is known about the long-term major cardiovascular events and bleeding complications of patients undergoing percutaneous coronary intervention (PCI) with radial vs femoral approach.

Methods: A total of 1107 patients from the CENTURY II trial were included. To minimize baseline differences between radial and femoral groups, we applied propensity-score matching for this comparison.

Results: In this multicenter study, the radial approach was used in 73.4% of patients. After propensity-score matching, baseline and procedural characteristics were comparable between both groups. Procedural success was high and similar in radial and femoral approaches (98.2% vs 97.5%; P=.47) while radial access was associated with a shorter hospital stay (1.69 ± 1.92 days vs 2.08 ± 1.98 days; P<.01). The short-term bleeding and vascular complication rates were significantly lower in the radial group (1.7% vs 6.2% [P<.001 in-hospital] and 2.7% vs 9.6% [P<.001 at 1-month follow-up]). At 3-year follow-up, radial access was associated with lower rates of all-cause mortality (3.9 vs 6.9%; P=.04) and cardiovascular death (2.1 vs 4.9%; P=.02). The composite of all-cause mortality, myocardial infarction, and revascularization showed no differences between groups (18.2 vs 21.1%; P=.29).

Conclusions: Compared to the femoral approach, the radial approach is associated with significantly lower long-term all-cause mortality rate as well as lower in-hospital and short-term bleeding rates. These results suggest additional long-term benefits of radial access for PCI, but should be interpreted within the context of the current study and further verified in future studies.

Keywords: access site; radial vs femoral.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Catheterization, Peripheral* / adverse effects
  • Catheterization, Peripheral* / methods
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / surgery*
  • Female
  • Femoral Artery / surgery*
  • Humans
  • Long Term Adverse Effects / diagnosis
  • Long Term Adverse Effects / etiology
  • Long Term Adverse Effects / mortality
  • Male
  • Middle Aged
  • Myocardial Revascularization / statistics & numerical data
  • Outcome and Process Assessment, Health Care
  • Percutaneous Coronary Intervention / methods*
  • Postoperative Hemorrhage / diagnosis
  • Postoperative Hemorrhage / etiology
  • Radial Artery / surgery*
  • Reoperation / statistics & numerical data